FCL

New Filing detected. See link for details.

Fineotex Chemical Limited announced the availability of the audio recording for its Investors and Analyst Call held on May 18, 2026. The call discussed the company's financial performance for Q4 FY 2025-2026, and the recording is accessible on the company's website.

Consolidated Revenue ₹313.73Cr vs ₹119.79Cr (▲162% YoY), EBITDA ₹43.69Cr vs ₹21.29Cr (▲105% YoY), PAT ₹43.79Cr vs ₹20.13Cr (▲118% YoY). EBITDA Margin 13.93% vs 17.77% (▼384bps). The company reported strong operational and financial performance, driven by the successful integration of its oilfield specialty chemicals business and expansion into a new 15-acre facility in Midland, enhancing capacity and capabilities.

Consolidated Revenue ₹313.73Cr vs ₹119.79Cr (▲161.91% YoY), Operational EBITDA ₹53.15Cr vs ₹28.83Cr (▲85.87% YoY), PAT ₹43.80Cr vs ₹20.13Cr (▲117.56% YoY). EBITDA Margin 16.94% vs 24.06% (▼712bps). A final dividend of Rs. 0.05/- per equity share was recommended.

Consolidated Revenue ₹313.73 Cr vs ₹119.79 Cr (▲161.91% YoY), EBITDA ₹53.15 Cr vs ₹28.83 Cr (▲85.87% YoY), PAT ₹43.80 Cr vs ₹20.13 Cr (▲117.56% YoY). EBITDA Margin 16.9% vs 24.1% (▼720bps).

Fineotex Chemical Limited announced an Earnings Conference Call with analysts and investors on Monday, May 18, 2026, at 10:00 AM (IST) to discuss the operational and financial performance for Q4 and Full Year FY2025-26.